Birdwatch Note Rating
2023-11-18 03:37:10 UTC - HELPFUL
Rated by Participant: CACBC4EC8C4E4D19376CEDA34D4EB5ADD4618462A48AECCCB728113F54B501B3
Participant Details
Original Note:
In the trial the effectiveness of the vaccine against severe RSV disease in babies was 81.8%. The clinical trial efficacy & safety data is publicly available. The available data are insufficient to establish a causal relationship between preterm birth & the vaccine https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants https://www.nejm.org/doi/10.1056/NEJMoa2216480 https://www.fda.gov/media/169361/download
All Note Details